Brugada syndrome and p.E61X_RANGRF.

BACKGROUND Brugada syndrome is an inherited cardiac condition transmitted with an autosomal dominant pattern which can lead to sudden cardiac death from malignant ventricular arrhythmias. The RANGRF gene has recently been proposed to be associated with Brugada syndrome. This gene encodes the MOG1 protein, a co-factor required for the full functioning of the cardiac sodium channel Nav1.5. The nonsense p.E61X genetic variation in the RANGRF gene has been postulated as responsible for Brugada syndrome although no clear association has been established. METHODS We clinically and genetically evaluated a Spanish family diagnosed with Brugada syndrome. A comprehensive genetic analysis of all genes to date responsible for Brugada syndrome was performed in the index case. RESULTS The index case was clinically diagnosed with Brugada syndrome after flecainide test. We identified a nonsense variation (p.E61X) in the index case and in other five family members. All of them showed a normal electrocardiogram in basal conditions. Flecainide test unmasked a type 1 Brugada syndrome electrocardiogram only in two of the relatives. CONCLUSIONS We suggest that p.E61X_RANGRF is a rare genetic variation with an uncertain role in Brugada Syndrome. Further studies must be performed to elucidate the potential pathogenic role of p.E61X_RANGRF in Brugada Syndrome.

[1]  M. Olesen,et al.  High prevalence of genetic variants previously associated with Brugada syndrome in new exome data , 2013, Clinical genetics.

[2]  Gene Kim,et al.  The role of redox signaling in epigenetics and cardiovascular disease. , 2013, Antioxidants & redox signaling.

[3]  Ludovic C. Gillet,et al.  Cardiac sodium channel NaV1.5 distribution in myocytes via interacting proteins: the multiple pool model. , 2013, Biochimica et biophysica acta.

[4]  M. Olesen,et al.  Letter by Olesen et al regarding article, "MOG1: a new susceptibility gene for Brugada syndrome". , 2011, Circulation. Cardiovascular genetics.

[5]  D. Phelan,et al.  Brugada Syndrome Caused by a Large Deletion in SCN5A Only Detected by Multiplex Ligation‐Dependent Probe Amplification , 2011, Journal of cardiovascular electrophysiology.

[6]  J. Svendsen,et al.  A novel nonsense variant in Nav1.5 cofactor MOG1 eliminates its sodium current increasing effect and may increase the risk of arrhythmias. , 2011, The Canadian journal of cardiology.

[7]  P. Schwartz,et al.  Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. , 2011, Heart rhythm.

[8]  J. Hancox,et al.  KCNE5 (KCNE1L) Variants Are Novel Modulators of Brugada Syndrome and Idiopathic Ventricular Fibrillation , 2011, Circulation. Arrhythmia and electrophysiology.

[9]  A. Leenhardt,et al.  MOG1: A New Susceptibility Gene for Brugada Syndrome , 2011, Circulation. Cardiovascular genetics.

[10]  K. Kusano ECG marker of high-risk in asymptomatic patients with Brugada syndrome. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[11]  M. Horie,et al.  Risk determinants in individuals with a spontaneous type 1 Brugada ECG. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[12]  Martin Borggrefe,et al.  Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. , 2010, Heart rhythm.

[13]  J. Ordovás,et al.  Epigenetics and cardiovascular disease , 2010, Nature Reviews Cardiology.

[14]  M. Ackerman,et al.  SCN5A allelic expression imbalance in African-Americans heterozygous for the common variant p.Ser1103Tyr , 2010, BMC Medical Genetics.

[15]  M Borggrefe,et al.  Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry , 2010, Circulation.

[16]  B. Hainque,et al.  Abstract 2713: MOG1 Mutations Associated With Brugada Syndrome Electrocardiogram Pattern , 2009 .

[17]  J. Pu,et al.  Readthrough of nonsense mutation W822X in the SCN5A gene can effectively restore expression of cardiac Na+ channels. , 2009, Cardiovascular research.

[18]  D. Tester,et al.  Cardiomyopathic and channelopathic causes of sudden unexplained death in infants and children. , 2009, Annual review of medicine.

[19]  K. Ueda,et al.  Role of HCN4 channel in preventing ventricular arrhythmia , 2009, Journal of Human Genetics.

[20]  M. Hande,et al.  Genomic imbalances in key ion channel genes and telomere shortening in sudden cardiac death victims , 2009, Cytogenetic and Genome Research.

[21]  A. Wilde,et al.  Ventricular Fibrillation with Prominent Early Repolarization Associated with a Rare Variant of KCNJ8/KATP Channel , 2009, Journal of cardiovascular electrophysiology.

[22]  C. Antzelevitch,et al.  Brugada syndrome: Recent advances and controversies , 2008, Current cardiology reports.

[23]  P. Szafranski,et al.  Identification of a New Co-factor, MOG1, Required for the Full Function of Cardiac Sodium Channel Nav1.5* , 2008, Journal of Biological Chemistry.

[24]  D. Conrad,et al.  Global variation in copy number in the human genome , 2006, Nature.

[25]  J. Ruijter,et al.  Diagnostic Value of Flecainide Testing in Unmasking SCN5A‐Related Brugada Syndrome , 2006, Journal of cardiovascular electrophysiology.

[26]  F. Sacher,et al.  Progressive Cardiac Conduction Defect is the Prevailing Phenotype in Carriers of a Brugada Syndrome SCN5A Mutation , 2006, Journal of cardiovascular electrophysiology.

[27]  Wataru Shimizu,et al.  Brugada syndrome: report of the second consensus conference. , 2005, Heart rhythm.

[28]  K. Buetow,et al.  Allelic variation in gene expression is common in the human genome. , 2003, Genome research.

[29]  J. Brugada,et al.  Brugada syndrome: a decade of progress. , 2002, Circulation research.

[30]  R. Hauer,et al.  Proposed diagnostic criteria for the Brugada syndrome: consensus report. , 2002, Circulation.

[31]  Andrew C. Zygmunt,et al.  Ionic and Cellular Basis for the Predominance of the Brugada Syndrome Phenotype in Males , 2002, Circulation.

[32]  Bert Vogelstein,et al.  Allelic Variation in Human Gene Expression , 2002, Science.

[33]  T. Nishimoto,et al.  A protein required for nuclear-protein import, Mog1p, directly interacts with GTP-Gsp1p, the Saccharomyces cerevisiae ran homologue. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Breithardt,et al.  Genetic basis and molecular mechanism for idiopathic ventricular fibrillation , 1998, Nature.

[35]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.

[36]  M. Ackerman,et al.  Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. , 2013, Translational research : the journal of laboratory and clinical medicine.

[37]  J. Towbin,et al.  An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. , 2010, Heart rhythm.

[38]  L. F. Lee,et al.  Brugada syndrome: unmasking a silent killer. , 2010, Nursing.

[39]  Charles Antzelevitch,et al.  The Brugada syndrome. , 2002, Current opinion in cardiology.